Background: Type 2 diabetes mellitus (T2DM) is a metabolic disease, characterized by chronic hyperglycemia. This pathology is linked to various genes whose interaction with the environment promotes its development. The aim of this work was to determine the relationship between the rs2241766 (T/G) polymorphism of the ADIPOQ gene with type 2 diabetes in the black population. Material and Methods: This work was a case-control study, involving type 2 diabetics subjects (n = 94) and controls (n = 82). The study took place from September 2022 to September 2023. Patients were recruited in the Endocrinology Department of the Libreville University Hospital Center. Analysis was performed in the Biochemistry laboratory of the University of Health Sciences in Libreville and at the Research Institute of Health Sciences of Bobodioulasso. Genomic DNA was extracted using the protocol Qiagen kit and the PCR-RFLP method was used to determine the rs2241766 (T/G) polymorphism of the ADIPOQ gene. Results: Only 2 genotypes were found in this population, the TT genotype and the GT genotype. The proportions were not different between the two groups (p = 0.1095) neither the distribution of G and T alleles (p = 0.1095). On the other hand, the HDL hypocholesterolemia was frequent in subjects with the GT genotype compared to TT heterozygous (51.1% vs 48.9%, p = 0.0280; OR = 0.55 [0.30 - 1.01]). Conclusion: There was no association between the rs2241766 (T/G) variant of the ADIPOQ gene and the occurrence of type 2 diabetes in this population. On the other hand, a relationship between HDL hypocholesterolemia and the GT genotype has been established.
References
[1]
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K.B., et al. (2020) Pathophysiology of Type 2 Diabetes Mellitus. International Journal of Molecular Sciences, 21, Article 6275. https://doi.org/10.3390/ijms21176275
[2]
International Diabetes Federation (2019) IDF Diabetes Atlas 2019. 9th Edition, International Diabetes Federation, Brussels.
[3]
International Diabetes Federation (2021) IDF Atlas 10th Edition 2021. 10th Edition, International Diabetes Federation, Brussels.
[4]
El-Lebedy, D. and Ashmawy, I. (2016) Common Variants in TCF7L2 and CDKAL1 Genes and Risk of Type 2 Diabetes Mellitus in Egyptians. Journal of Genetic Engineering and Biotechnology, 14, 247-251. https://doi.org/10.1016/j.jgeb.2016.10.004
[5]
Mohd Imran, A.A. (2015) Genetic Polymorphism of Adiponectin, a Potential Biomarker in Type-II Diabetes Mellitus. Molecular Biology, 4, 127. https://doi.org/10.4172/2168-9547.1000127
[6]
Achari, A.E. and Jain, S.K. (2017) Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. International Journal of Molecular Sciences, 18, Article 1321. https://doi.org/10.3390/ijms18061321
[7]
Howlader, M., Sultana, M.I., Akter, F. and Hossain, M.M. (2021) Adiponectin Gene Polymorphisms Associated with Diabetes Mellitus: A Descriptive Review. Heliyon, 7, e07851. https://doi.org/10.1016/j.heliyon.2021.e07851
[8]
Mackawy, A.M. (2013) Association of the 45T > G Adiponectin Gene Polymorphism with Insulin Resistance in Non-Diabetic Saudi Women. Gene, 530, 158-163. https://doi.org/10.1016/j.gene.2013.07.003
[9]
Hussain, M.K., Deli, F.A., Algenabi, A.H.A. and Abdul-Rudha, K.H. (2018) Adiponectin Gene Polymorphisms as a Predictor for Development of Type 2 Diabetes Mellitus in Iraqi Population. Gene, 662, 118-122. https://doi.org/10.1016/j.gene.2018.03.087
[10]
Han, Q., Geng, W., Zhang, D., Cai, G. and Zhu, H. (2020) ADIPOQ rs2241766 Gene Polymorphism and Predisposition to Diabetic Kidney Disease. Journal of Diabetes Research, 2020, Article ID: 5158497. https://doi.org/10.1155/2020/5158497
[11]
Alfaqih, M.A., Al-Hawamdeh, A., Amarin, Z.O., Khader, Y.S., Mhedat, K. and Allouh, M.Z. (2022) Single Nucleotide Polymorphism in the ADIPOQ Gene Modifies Adiponectin Levels and Glycemic Control in Type Two Diabetes Mellitus Patients. BioMed Research International, 2022, Article ID: 6632442. https://doi.org/10.1530/endoabs.81.P61
[12]
World Medical Association (2013) World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA, 310, 2191-2194. https://doi.org/10.1001/jama.2013.281053
[13]
American Diabetes Association (2020) Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes. Diabetes Care, 43, S14-S31. https://doi.org/10.2337/dc20-S002
[14]
Friedewald, W.T., Levy, R.I. and Fredrickson, D.S. (1972) Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, without Use of the Preparative Ultracentrifuge. Clinical Chemistry, 18, 499-502. https://doi.org/10.1093/clinchem/18.6.499
[15]
Abessolo Félix, O., Bengone Aude Syntia, M., Atome Guy Roger, N., Alvine Sybille, B. and Edou, M. (2018) Relationship between Sweat Function Determined by the Sudoscan and Parameters of the Metabolic Syndrome in People with Type 2 Diabetes. International Journal of Clinical Biochemistry and Research, 5, 560-564. https://doi.org/10.18231/2394-6377.2018.0119
[16]
Agyemang-Yeboah, F., Eghan, B.A.J., Annani-Akollor, M.E., Togbe, E., Donkor, S. and Oppong Afranie, B. (2019) Evaluation of Metabolic Syndrome and Its Associated Risk Factors in Type 2 Diabetes: A Descriptive Cross-Sectional Study at the Komfo Anokye Teaching Hospital, Kumasi, Ghana. BioMed Research International, 2019, Article ID: 4562904. https://doi.org/10.1155/2019/4562904
[17]
Tsai, M.K., Wang, H.M., Shiang, J.C., Chen, I.H., Wang, C.C., Shiao, Y.F., Liu, W.S., Lin, T.J., Chen, T.M. and Chen, Y.H. (2014) Sequence Variants of ADIPOQ and Association with Type 2 Diabetes Mellitus in Taiwan Chinese Han Population. The ScientificWorldJournal, 2014, Article ID: 650393. https://doi.org/10.1155/2014/650393
[18]
Farooq, R., Majid, S., Ahmad Bhat, S., Amin, S., Bhat, M.H., Ahmad Wani, H., et al. (2018) Association of Adiponectin Gene Polymorphism with Type 2 Diabetes and Metabolic Syndrome. Translational Metabolic Syndrome Research, 1, 39-47. https://doi.org/10.1016/j.tmsr.2018.09.002
[19]
Gao, M., Ding, D., Huang, J., Qu, Y., Wang, Y. and Huang, Q. (2013) Association of Genetic Variants in the Adiponectin Gene with Metabolic Syndrome: A Case-Control Study and a Systematic Meta-Analysis in the Chinese Population. PLOS ONE, 8, e58412. https://doi.org/10.1371/journal.pone.0058412
[20]
Hamidi, Y., Saki, S., Afraz, E.S. and Pashapour, S. (2022) A Meta-Analysis of ADIPOQ rs2241766 Polymorphism Association with Type 2 Diabetes. Journal of Diabetes & Metabolic Disorders, 21, 1895-1901. https://doi.org/10.1007/s40200-022-01086-0
[21]
Sahli, S., Khlifi, L., Jaballah, A., Khelil, S., Bouzidi, N., Chahed, H., et al. (2017) Evaluation of Serum Adiponectin and Adipoq 45 t > g Polymorphism with Metabolic Syndrome in Tunisian Population. International Journal of Pharma Sciences and Research, 8, 1294-1300.
[22]
Lu, J.F., Zhou, Y., Huang, G.H., Jiang, H.X., Hu, B.L. and Qin, S.Y. (2014) Association of ADIPOQ Polymorphisms with Obesity Risk: A Meta-Analysis. Human Immunology, 75, 1062-1068. https://doi.org/10.1016/j.humimm.2014.09.004
[23]
Wu, J., Liu, Z., Meng, K. and Zhang, L. (2014) Association of Adiponectin Gene (ADIPOQ) rs2241766 Polymorphism with Obesity in Adults: A Meta-Analysis. PLOS ONE, 9, e95270. https://doi.org/10.1371/journal.pone.0095270
[24]
Mbang Bengone, A.S., Nikiema-Ndong Nsame, D., Batou, S., Nsi Emvo, E. and Ovono Abessolo, F. (2023) Evaluating Metabolic Syndrome Criteria in Gabonese Type 2 Diabetes Patients. African Journal of Health Sciences, 36, 215-223. https://doi.org/10.4314/ajhs.v36i3.4
[25]
Yanai, H. and Yoshida, H. (2019) Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives. International Journal of Molecular Sciences, 20, Article 1190. https://doi.org/10.3390/ijms20051190
[26]
Zhou, J.M., Zhang, M., Wang, S., Wang, B.Y., Han, C.Y., Ren, Y.C., et al. (2016) Association of the ADIPOQ Rs2241766 and Rs266729 Polymorphisms with Metabolic Syndrome in the Chinese Population: A Meta-analysis. Biomedical and Environmental Sciences, 29, 505-515.
[27]
Zahary, M.N., Harun, N.S., Ridzwan, N., Jumli, M.N., Khalili Rohin, M.A., Yahaya, R.,et al. (2020) Increased Risk of Metabolic Syndrome with Genetic Polymorphism of ADIPOQ among a Temiar Population in Malaysia. Meta Gene, 24, Article ID: 100653. https://doi.org/10.1016/j.mgene.2020.100653
